BioSpace News Archive

Charles River Laboratories today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure.

The conference, which is being held February 5-9, 2018 in San Diego, CA, presents the latest information from basic science, translational research and clinical trials for lysosomal diseases.

The six posters evaluate the safety of Cladribine Tablets and its impact on the immune system via post hoc analyses of the CLARITY, CLARITY Extension, and ORACLE-MS trials, as well as the PREMIERE registry study.

A002 previously received orphan drug designation from the FDA and the European Medicines Agency for the treatment of ACHM in 2016.

Neogen that it has released BetaStar Advanced -- the easiest method to test for antibiotics in milk.

Under the terms of the agreement, Elekta will now offer EQUICARE CS™ and Equicare’s Active Patient Portal to current and future users of Elekta’s MOSAIQ® Oncology Electronic Health Record (EHR). EQUICARE CS and the Active Patient Portal complement MOSAIQ, facilitating communication between patients and clinicians with no geographic restrictions.

HeartFlow, Inc. today announced that seven new commercial payers issued positive medical policies covering the use of the HeartFlow FFRct Analysis following a coronary computed tomography angiogram (CCTA).

As at January 31, 2018, the Company’s issued ordinary share capital comprised 910,039,956 ordinary shares of 5 pence each with voting rights and a further 7,357,283 ordinary shares held in treasury.

Dr. Paul has been with the company for six years since its inception, initially as president of R&D,

Broad leadership and financial expertise adds to our board’s breadth of talent and background.